While significant advances in cancer biology have been made from research on tumour cells in culture, it has become increasingly clear that to gain a complete understanding of the complexity of tumour development, and to develop and translate rationally-designed targeted therapies, studies are also required in an animal model. Mice are now the most widely used animal model for the study of cancer and this year’s conference will highlight the development and application of these models in the study of malignant disease. The conference will fall broadly within a number of key areas ranging from the development of sophisticated allele-specific and tissue-specific animal models to their use in the study of specific cancer types, the engagement of tumour with immune cells and the microenvironment, metastatic disease and therapeutic resistance.

Deadline for abstract submissions is 3 May 2024

More information and to register